Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.21 USD | +1.26% | +1.60% | +11.62% |
05-09 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
04-17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.62% | 120M | |
+9.14% | 114B | |
+11.50% | 104B | |
-13.79% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.74% | 17.89B | |
+7.77% | 14.28B | |
+34.72% | 12.55B |
- Stock Market
- Equities
- DMAC Stock
- News DiaMedica Therapeutics Inc.
- DiaMedica Therapeutics : Oppenheimer Starts DiaMedica Therapeutics at Outperform With $27 Price Target